Publications: Prof Farida Fortune

Oyenuga VO, Mosler G, Addo-Yobo E, Adeyeye OO, Arhin B, Fortune F, Griffiths CJ, Kasekete M et al. ( 2024 ) . Asthma symptoms, severity, and control with and without a clinical diagnosis of asthma in early adolescence in sub-Saharan Africa: a multi-country, school-based, cross-sectional study . The Lancet Child & Adolescent Health vol. 8 , ( Eur Respir J 17 2001 ) 859 - 871 .

Moots RJ, Fortune F, Jackson R, Thornburn T, Morgan A, Carr DF, Murray PI, Wallace GR et al. ( 2024 ) . Infliximab versus interferon-alpha in the treatment of Behçet’s Syndrome: Clinical data from the BIO-BEHÇET’S randomised controlled trial . Rheumatology

Macken JH, Senusi A, O’Toole EA, Caley M, Rognoni E, Fortune F ( 2024 ) . Erosive lichen planus: an unmet disease burden . Frontiers in Medicine vol. 11 ,

Sevimli E, Günay S, Aliyeva A, Aksoy B, Fortune F, Inanc N, Mumcu G ( 2024 ) . Psychological resilience in patients with primary Sjögren's syndrome: effect of involvement of major salivary and lacrimal glands . European Journal Of Oral Sciences vol. 132 , ( 6 )

Sevimli E, Günay S, Aliyeva A, Fortune F, Mumcu G ( 2024 ) . Assessment of Psychological Resilience in Primary Sjögren Syndrome . International Dental Journal vol. 74 , s76 - s77 .

Moots RJ, Fortune F, Jackson R, Thornburn T, Morgan AW, Carr D, Murray PI, Wallace GR et al. ( 2024 ) . Infliximab versus alpha interferon in the treatment of Behçet's disease: the BIO BEHÇET'S RCT . Efficacy and Mechanism Evaluation vol. 11 , ( 17 ) 1 - 77 .

Sevimli E, Gunay S, Aliyeva A, Sari FB, Şişman Kitapçi N, Fortune F, Inanc N, Mumcu G ( 2024 ) . AB0857 ASSOCIATIONS AMONG PATIENT EMPOWERMENT, PATIENT ENGAGEMENT, PATIENT ACTIVATION AND CLINICAL MANIFESTATIONS IN PRIMARY SJÖGREN’S SYNDROME . Conference: Scientific Abstracts1727.2 - 171728 .

Altıngöz EN, Yenisoy Y, Kapusuz A, Abacar K, Şişman-Kitapçı N, Yay M, Karacaylı U, Alibaz-Öner F et al. ( 2024 ) . The mediator role of treatment response on oral health related quality of life in Behçet’s syndrome . Medicina Oral Patología Oral y Cirugia Bucal vol. 29 , ( 3 ) e350 - e355 .

Lim S, Said B, Zurba L, Mosler G, Addo-Yobo E, Adeyeye OO, Arhin B, Evangelopoulos D et al. ( 2023 ) . Characterising sources of PM2·5 exposure for school children with asthma: a personal exposure study across six cities in sub-Saharan Africa . The Lancet Child & Adolescent Health vol. 8 , ( 1 ) 17 - 27 .

Fortune F ( 2023 ) . Cardiovascular system . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Care of the elderly and children . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Dermatology . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Disability . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Endocrine disorders and disorders of bone metabolism . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Human disease . Essential Skills for Dentists , Oxford University Press (OUP)

Fortune F ( 2023 ) . Medical emergencies including therapeutics . Essential Skills for Dentists , Oxford University Press (OUP)

Fortune F ( 2023 ) . Psychiatry . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . Reproductive system . Human disease for dentistry , Oxford University Press (OUP)

Fortune F ( 2023 ) . The nervous system . Human disease for dentistry , Oxford University Press (OUP)

Çandereli ZÖ, Arslan T, Özdamar Ö, Yay M, Karaçayli Ü, Şişman-Kitapçi N, Adesanya A, Aksoy A et al. ( 2023 ) . Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome? . Clinical and Experimental Rheumatology vol. 41 , ( 10 ) 2078 - 2086 .

Kidd DP, Kibrom H, Ssendi E, Hall M, Fortune F ( 2023 ) . Gastrointestinal dysmotility complicating Behçet's syndrome: description of a newly recognised clinical phenotype . Clinical and Experimental Rheumatology vol. 41 , ( 10 ) 2087 - 2092 .

Gokani B, Sacoor S, Leisegang GR, Ogunkolade W, Bibi A, Grigoriadou S, Pade C, Gibbons J et al. ( 2023 ) . Behçet's patients' response to COVID-19 vaccination . Clinical Immunology vol. 255 ,

Marinello D, Cam E, Di Cianni F, Forrest L, Fortune F, Hatemi G, Higgins S, Italiano N et al. ( 2023 ) . AB0773 IMPROVING ADHERENCE TO TREATMENT IN BEHÇET’S DISEASE - THE MULTI-STAKEHOLDER IMPACT_BD INTERNATIONAL STUDY . Conference: Scientific Abstracts1595 - 1596 .

Moots R, Fortune F, Jackson R, Thornburn T, Morgan A, Carr D, Murray P, Wallace G et al. ( 2023 ) . POS0220 THE BIOBEHÇET’S TRIAL: OPTIMAL UTILISATION OF BIOLOGIC DRUGS IN BEHÇET’S DISEASE: A RANDOMISED CONTROLLED TRIAL OF INFLIXIMAB VS ALPHA INTERFERON, WITH GENOTYPING AND METABOLOMIC PROFILING, TOWARDS A STRATIFIED MEDICINES APPROACH TO TREATMENT . Conference: Scientific Abstracts337.1 - 33337 .

Yenissoy Y, Altıngöz EN, Kapusuz A, Abacar K, Tatlı I, Türe‐Özdemir F, Karacaylı U, Yay M et al. ( 2023 ) . A cross‐sectional study on activity impairment in primary Sjogren's syndrome . Oral Diseases vol. 30 , ( 4 ) 2234 - 2244 .

Ogunkolade W, Senusi AA, Desai P, Sacoor S, Bibi A, Gokani B, Sandionigi A, Fortune F ( 2023 ) . Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease . Clinical Immunology vol. 253 ,

Senusi AA, Mather J, Ola D, Bergmeier LA, Gokani B, Fortune F ( 2022 ) . The impact of multifactorial factors on the Quality of Life of Behçet's patients over 10 years . Frontiers in Medicine vol. 9 ,

Lee J-I, Hsu W-Y, Huang C-L, Chang S-S, Shaw FF-T, Yu H-T, Yang L-X ( 2022 ) . Taiwan National Suicide Prevention Hotline callers’ suicide risk level and emotional disturbance difference during and before COVID-19 . Asian Journal of Psychiatry vol. 80 ,

Caetano AJ, Caetano A, Sharpe P, Volponi AA, Yianni V, Bush M, McKay LK, Wallet S et al. ( 2022 ) . A Roadmap for the Human Oral and Craniofacial Cell Atlas . Journal of Dental Research vol. 101 , ( 11 ) 1274 - 1288 .

Joury E, Kisely S, Watt RG, Ahmed N, Morris AJ, Fortune F, Bhui K ( 2022 ) . Mental Disorders and Oral Diseases: Future Research Directions . J Dent Res220345221120510 - 220345221120510 .

Fortune F, Mather J, Şişman-Kitapci N, Gokani B, Senusi AA, Mumcu G ( 2022 ) . The impact of the COVID-19 pandemic on patients with Behçet's syndrome within the framework of Maslow's hierarchy of needs: implications for patient empowerment in national or global emergencies . Clinical and Experimental Rheumatology vol. 41 , ( 10 ) 1976 - 1984 .

Mumcu G, Abacar K, Tatli İ, Türe-Özdemir F, Kitapçi OC, Şişman Kitapçi N, Yay M, Karaçayli Ü et al. ( 2022 ) . AB0574 PREDICTOR FACTORS IN EMPOWERMENT OF PATIENTS WITH PRIMARY SJOGREN SYNDROME IN THE FRAME OF VALUE BASED HEALTH CARE . Annals of the Rheumatic Diseases vol. 81 , ( Suppl 1 ) 1413.1 - 141413 .

Chandratre P, Chandan J, Hunjan M, Trudgill N, Moots R, Fortune F, Situnayake RD ( 2022 ) . P093 Prevalence and incidence of Behçet’s Disease in England: A multicentre retrospective observational study . Rheumatology vol. 61 , ( Supplement_1 )

Yenisoy Y, Altingoz EN, Kapusuz A, Abacar KY, Tatli I, Ture-Ozdemir F, Karacayli U, Yay M et al. ( 2022 ) . DOES EULAR SJOGREN'S SYNDROME PATIENT REPORTED INDEX (ESSPRI)-PAIN MODERATE DAILY ACTIVITY IMPAIRMENT IN PATIENTS WITH PRIMARY SJOGREN SYNDROME? . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 40 , 62 - 63 .

Novak T, Hamedi M, Bergmeier LA, Fortune F, Hagi-Pavli E ( 2021 ) . Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet’s Disease . Frontiers in Immunology vol. 12 , ( 22 ) Article 724900 , 724900 - 724920 .

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Shea B, Cam E, Gul A et al. ( 2021 ) . The OMERACT Core Set of Domains for Outcome Measures in Behçet Syndrome . Arthritis Care Res (Hoboken) vol. https://doi.org/10.1 ,

ZOU L, FORTUNE F, NIBALI L, GKRANIAS N, MARDAS N, DONOS N . 3D Sequential Spacal and Thermal Measurements . Conference: Proceedings of 3DBODY.TECH 2021 - 12th International Conference and Exhibition on 3D Body Scanning and Processing Technologies, Lugano, Switzerland, 19-20 October 2021

Pain CE, Beresford MW, Fortune F, Lai ETC, Murphy R, Taylor-Robinson D, Brogan PA, Moots RJ ( 2021 ) . Behçet's syndrome in children and young people in the United Kingdom and the Republic of Ireland: A prospective epidemiological study . Rheumatology (United Kingdom) vol. 60 , ( 10 ) Article 20-23-42 , 4728 - 4736 .

Karacayli U, Adesanya A, Aksoy A, Belem JMFM, Cardin NB, Sarı FB, Beyhan TE, Çelik Z et al. ( 2021 ) . The assessment of presenteeism and activity impairment in Behçet’s syndrome and recurrent aphthous stomatitis: a multicentre study . Rheumatology vol. 61 , ( 4 ) 1538 - 1547 .

Mumcu G, Fortune F ( 2021 ) . Oral Health and Its Aetiological Role in Behçet's Disease . Frontiers in Medicine vol. 8 ,

Zouboulis CC, van Laar JAM, Schirmer M, Emmi G, Fortune F, Gül A, Kirino Y, Lee E et al. ( 2021 ) . Adamantiades‐Behçet's disease (Behçet's disease) and COVID‐19 . Journal of the European Academy of Dermatology and Venereology vol. 35 , ( 9 ) e541 - e543 .

Huang Y, Jedličková H, Cai Y, Rehman A, Gammon L, Ahmad US, Uttagomol J, Parkinson EK et al. ( 2021 ) . Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris . Frontiers in Immunology vol. 12 ,

Macken JH, Fortune F, Buchanan JAG ( 2020 ) . Remote telephone clinics in oral medicine: reflections on the place of virtual clinics in a specialty that relies so heavily on visual assessment. A note of caution . British Journal of Oral and Maxillofacial Surgery vol. 59 , ( 5 ) 605 - 608 .

Lalli A, Aldehlawi H, Buchanan JA, Seoudi N, Fortune F, Waseem A ( 2020 ) . Screening for oral cancer utilising risk-factor analysis is ineffective in high-risk populations . British Journal of Oral and Maxillofacial Surgery

Novak T, Fortune F, Bergmeier L, Khan I, Hagi-Pavli E ( 2020 ) . Neutrophil elastase and endogenous inhibitors in Behçet’s disease saliva . Clinical and Experimental Immunology

Senusi A, Kang A, Buchanan JAG, Adesanya A, Aloraini G, Stanford M, Fortune F ( 2020 ) . New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease . British Journal of Oral and Maxillofacial Surgery vol. 58 , ( 8 ) 1034 - 1039 .

Sacoor S, Chana S, Fortune F ( 2020 ) . The dental team as part of the medical workforce during national and global crises . British Dental Journal vol. 229 , ( 2 ) 89 - 92 .

Houacine S, Kang A, Parkinson EK, Wan H, Fortune F ( 2020 ) . Induction of p53 in keratinocyte cultures treated with Behçet's patient sera . Journal of Oral Pathology and Medicine vol. 49 , ( 5 ) 435 - 442 .

Fortune F, Hatemi G ( 2019 ) . Behçet Syndrome and Microbes . Behçet Syndrome , Springer Nature

Petrushkin H, Norman PJ, Lougee E, Parham P, Wallace GR, Stanford MR, Fortune F ( 2019 ) . KIR3DL1/S1 allotypes contribute differentially to the development of Behçet disease . Journal of Immunology vol. 203 , ( 6 ) 1629 - 1635 .

Senusi A, Liu J, Bevec D, Bergmeier LA, Stanford M, Kidd D, Jawad A, Higgins S et al. ( 2018 ) . The association of alpha-melanocyte stimulating hormone, vasoactive intestinal peptide with fatigue and quality of sleep in Behcet's disease . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . Conference: 18th International Conference on Behcet's Disease vol. 36 , S156 - S156 .

Senusi AA, Liu J, Bevec D, Bergmeier LA, Stanford M, Kidd D, Jawad A, Higgins S et al. ( 2018 ) . Why are Behçet's disease patients always exhausted? . Clinical and Experimental Rheumatology vol. 36 , ( 6 Suppl 115 ) 53 - 62 .

Senusi A, Higgins S, Fortune F ( 2018 ) . The influence of oral health and psycho-social well-being on clinical outcomes in Behçet’s disease . Rheumatology International vol. 38 , ( 10 ) 1873 - 1883 .

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F et al. ( 2018 ) . Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations . Rheumatology (Oxford) vol. 57 , ( 12 ) 2200 - 2212 .

Liu J, Zheng F, Rawlinson SCF, Fortune F, Kim DG ( 2018 ) . Bone biology and bioactive glass in bone regeneration . Bone Regeneration: Concepts, Clinical Aspects and Future Directions ,

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F et al. ( 2018 ) . Management of skin, mucosa and joint involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome . Seminars in Arthritis and Rheumatism vol. 48 , ( 4 ) 752 - 762 .

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A et al. ( 2018 ) . 2018 update of the EULAR recommendations for the management of Behçet’s syndrome . Annals of the Rheumatic Diseases vol. 77 , ( 6 )

Bergmeier LA, Fortune F ( 2018 ) . Clinical Management of Oral Mucosal Disease: A Literature Review . Oral Mucosa in Health and Disease , Springer Nature

Bergmeier LA, Fortune F ( 2018 ) . Non-infectious Diseases of the Oral Mucosa: The Importance of Immune Functions . Oral Mucosa in Health and Disease , Springer Nature

Rice H, Beresford MW, Brogan P, Fortune F, Moots RJ, Murphy R, Pain CE ( 2018 ) . 20. British Paediatric Surveillance Unit (BPSU) study of Behçet’s syndrome in children and young people in the United Kingdom . Rheumatology vol. 56 , ( suppl_7 )

Mumcu G, Adesenya A, Aksoy A, Belem JMFM, Cardin N, Alibaz-Oner F, Ergun T, Inanc N et al. ( 2018 ) . An unmet need for oral ulcer activity in patients with Behcet's disease: a multi-national study . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 36 , S183 - S183 .

Pain CE, Latham E, Beresford MW, Fortune F, Moots RJ, Murphy R, Smith E, Taylor-Robinson D et al. ( 2018 ) . Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 36 , S186 - S186 .

Mumcu G, Celik Z, Adesanya A, Aksoy A, Belem JMFM, Cardin N, Alibaz-Oner F, Ergun T et al. ( 2018 ) . The assessment of work productivity and activity impairment in patients with Behcet's disease: a multi-national study . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 36 , S197 - S197 .

Petrushkin H, Norman P, Wallace G, Stanford M, Parham P, Fortune F ( 2018 ) . The combination of a low expressing KIR3DL1 allotype and KIR3DS1 contributes toward the risk of developing Behcet's disease . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 36 , S154 - S154 .

Senusi AA, Ola D, Mather J, Mather J, Fortune F ( 2017 ) . Behçet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status . Clinical and Experimental Rheumatology vol. 35 Suppl 108 , ( 6 ) 43 - 50 .

Moots RJ, Fortune F, Situnayake D ( 2017 ) . The Behçet’s centres of excellence . Rheumatology vol. 57 , ( 4 ) 594 - 595 .

Hasan MS, Ryan PL, Bergmeier LA, Fortune F ( 2017 ) . Circulating NK cells and their subsets in Behçet's disease . Clinical and Experimental Immunology vol. 188 , ( 2 )

Rice H, Beresford MW, Brogan P, Fortune F, Moots RJ, Murphy R, Pain CE ( 2017 ) . BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM . RHEUMATOLOGY . vol. 56 ,

Senusi AA, Ola D, Mather J, Mather J, Fortune F ( 2017 ) . Behcet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY vol. 35 , ( 6 ) S43 - S50 .

Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. ( 2016 ) . Next-generation sequencing demonstrates dynamic recirculation of B cell clones in ectopic lymphoid structures of Sjogren's syndrome . EUROPEAN JOURNAL OF IMMUNOLOGY . Conference: European League Against Rheumatism vol. 46 , 939 - 940 .

Liu J, Rawlinson S, Hill R, FORTUNE F ( 2016 ) . Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects . Dental Materials vol. 32 , ( 10 ) e221 - e237 .

Liu J, Rawlinson SCF, Hill RG, Fortune F ( 2016 ) . Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects . Dental Materials vol. 32 , ( 3 ) 412 - 422 .

Petrushkin H, Senusi A, Hasan SM, Liu J, Mercadante V, Wakjira N, Kidd D, Buckland M et al. ( 2016 ) . A SUBGROUP ANALYSIS OF COMORBIDITIES IN BEHCET'S DISEASE; RESULTS FROM A PROSPECTIVE CASE-CONTROLLED STUDY . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S171 - S172 .

Pain C, Rice H, Beresford M, Brogan P, Fortune F, Moots R, Murphy R ( 2016 ) . BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S157 - S157 .

Hasan S, Bergmeier LA, Fortune F ( 2016 ) . CD16+VΔ2 T CELLS AND THEIR FUNCTIONAL POTENTIAL IN BEHCET'S DISEASE . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S153 - S153 .

Situnayake RD, Mitton DL, Murray PI, Damato EM, Carruthers D, Hamburger J, Richards A, Douglas S et al. ( 2016 ) . ESTABLISHING A NATIONAL SERVICE FOR BEHCET'S SYNDROME IN THE UK - EXPERIENCE OF THE FIRST FOUR YEARS . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S163 - S163 .

Bergmeier LA, Malik A, Boukbir N, Hasan S, Fortune F ( 2016 ) . EXPRESSION OF HOMING MAKERS ON PERIPHERAL BLOOD LYMPHOCYTES IN BEHCET'S DISEASE PATIENTS AND HEALTHY CONTROLS . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S140 - S140 .

Petrushkin HJD, Stanford M, Fortune F, Jawad A ( 2016 ) . Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis . Clinical and experimental rheumatology vol. 34 , ( 1 ) S18 - S19 .

Senusi A, Buckland M, Jawad A, Kidd D, Stanford M, Fortune F ( 2016 ) . THE EFFECT OF MEDICATION ON THE TREATMENT OUTCOMES OF BEHCET DISEASE . CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . vol. 34 , S186 - S187 .

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F et al. ( 2016 ) . a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome . ARTHRITIS & RHEUMATOLOGY . vol. 68 ,

Petrushkin HJD, Stanford M, Fortune F, Jawad A ( 2015 ) . Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis . Clinical and Experimental Rheumatology vol. 34 , ( 1 Suppl 95 ) s18 - s19 .

Hasan S, Bergmeier LA, Petrushkin H, Fortune F ( 2015 ) . Gamma Delta (γδ) T Cells and Their Involvement in Behçet’s Disease . Journal of Immunology Research vol. 2015 , ( 1 )

Senusi A, Seoudi N, Bergmeier LA, Fortune F ( 2015 ) . Genital ulcer severity score and genital health quality of life in Behçet’s disease . Orphanet Journal of Rare Diseases vol. 10 , ( 1 )

Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. ( 2015 ) . FRI0020 Next-Generation Sequencing Demonstrates Dynamic Recirculation of B Cell Clones in Ectopic Lymphoid Structures of Sjögren's Syndrome . Annals of the Rheumatic Diseases . vol. 74 ,

Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Fortune F ( 2015 ) . The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis . Journal of Oral Microbiology vol. 7 , ( 1 )

Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F ( 2015 ) . The oral mucosal and salivary microbial community of Behçet's syndrome and recurrent aphthous stomatitis . Journal of Oral Microbiology vol. 7 , ( 1 )

Petrushkin H, Hasan S, Stanford MR, Fortune F, Wallace GR ( 2015 ) . Behçet’s Disease: Do Natural Killer Cells Play a Significant Role? . Frontiers in Immunology vol. 6 ,

Petrushkin H, Stanford M, Fortune F, Jawad AS ( 2015 ) . Clinical Review: Familial Mediterranean Fever—An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment . Ocular Immunology and Inflammation vol. 24 , ( 4 ) 422 - 430 .

Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. ( 2015 ) . Next-Generation Sequencing Demonstrates Dynamic Recirculation of B Cell Clones in Ectopic Lymphoid Structures of Sjogren's Syndrome . SCANDINAVIAN JOURNAL OF IMMUNOLOGY . vol. 81 , 401 - 402 .

Gadhia T, Adegun OK, Fortune F ( 2014 ) . Brown tumours: widespread involvement of multiple maxillofacial bones and cervical spine . BMJ Case Reports vol. 2014 ,

Hamedi M, Bergmeier LA, Hagi-Pavli E, VARTOUKIAN SR, Fortune F ( 2014 ) . Differential expression of Suppressor of Cytokine Signalling proteins in Behçet’s Disease . Scandinavian Journal of Immunology vol. 80 , ( 5 ) 369 - 376 .

VARTOUKIAN SR, Tilakaratne W, Seoudi N, Bombardieri M, Bergmeier L, Tappuni A, Fortune F ( 2014 ) . Dysregulation of the SOCS3-STAT3 pathway in the aetio-pathogenesis of Sjögren’s syndrome . Clinical and Experimental Immunology vol. 177 , ( 3 ) 618 - 629 .

Adegun OK, Abdelghani A, Fortune F ( 2014 ) . Oral manifestation of plantar–palmar fibromatosis . BMJ Case Reports vol. 2014 ,

Zou L, Adegun OK, Willis A, Fortune F ( 2014 ) . Facial biometrics of peri-oral changes in Crohn's disease . Lasers Med Sci vol. 29 , ( 3 ) 869 - 874 .

Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Curtis MA, Fortune F ( 2014 ) . The role of TLR2 and 4 in Behçet's disease pathogenesis . Innate Immun vol. 20 , ( 4 ) 412 - 422 .

Preshaw P ( 2014 ) . Summary of: Type 2 diabetes risk screening in dental practice settings: a pilot study . British Dental Journal vol. 216 , ( 7 ) 416 - 417 .

Wright D, Muirhead V, Weston-Price S, Fortune F ( 2014 ) . Type 2 diabetes risk screening in dental practice settings: a pilot study . British Dental Journal vol. 216 , ( 7 ) e15 - e15 .

Needleman I, Ashley P, Petrie A, Fortune F, Turner W, Jones J, Niggli J, Engebretsen L et al. ( 2014 ) . ORAL HEALTH AND IMPACT ON PERFORMANCE OF ATHLETES PARTICIPATING IN THE LONDON 2012 OLYMPIC GAMES . British Journal of Sports Medicine vol. 48 , ( 7 )

Murray-Brown W, Picarelli G, Vartoukian S, Sutcliffe N, Fortune F, Valesini G, Pitzalis C, Tappuni A et al. ( 2014 ) . AB0222 Monocyte-derived IL-32 expression correlates with the level of inflammation in salivary glands of sjÖgren’s syndrome . Annals of the Rheumatic Diseases vol. 71 , ( Suppl 3 )

Murray-Brown W, Croia C, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Pitzalis C, Bombardieri M ( 2014 ) . OP0080 Lesional IL-21 Expression Correlates with Functional Germinal Center Formation and T Follicular Helper Cell Infiltration in the Salivary Glands of Sjögren’s Syndrome . Annals of the Rheumatic Diseases vol. 72 , ( Suppl 3 )

Merashli M, Jawad A, Gokani B, Fortune F ( 2014 ) . Behcet disease among White British and Mediterranean Ethnicities . ORAL DISEASES vol. 20 , 22 - 22 .

Hasan MS, Ryan PL, Bergmeier LA, Fortune F ( 2014 ) . CD27 distinguishes human NK and Vδ2 cells into distinct subsets in Behcet's disease . IMMUNOLOGY . vol. 143 , 113 - 113 .

Zou L, Adegun OK, Willis A, Fortune F ( 2014 ) . Facial biometrics of peri-oral changes in Crohn's disease . Lasers in Medical Science vol. 29 , ( 3 ) 869 - 874 .

Bergmeier LA, Hamedi M, Hagi-Pavli E, Seoudi N, Senusi A, Ijaz H, Fortune F ( 2014 ) . HSP27 as a diagnostic marker in the saliva of Behcet's disease .

Gokani B, Merashli M, Fortune F ( 2014 ) . Impact of biologic therapies for behcets disease . ORAL DISEASES vol. 20 , 20 - 21 .

Fortune F ( 2014 ) . The clinical presentation of Behcet's disease - why is diagnosis so often delayed? . ORAL DISEASES vol. 20 , 2 - 2 .

Hasan MDS, Bergmeier LA, Fortune F ( 2014 ) . Vitamin-D status and its regulation of γδ T-cells in Behcet's disease . IMMUNOLOGY . vol. 143 , 42 - 42 .

Adegun OK, Zou L, Willis A, Fortune F ( 2013 ) . Facial biometrics: a novel technique for evaluation of morphological changes in orofacial Crohn's disease . BMJ case reports vol. 2013 ,

Adegun OK, Zou L, Willis A, Fortune F ( 2013 ) . Facial biometrics: a novel technique for evaluation of morphological changes in orofacial Crohn's disease . BMJ Case Rep vol. 2013 ,

Needleman I, Ashley P, Petrie A, Fortune F, Turner W, Jones J, Niggli J, Engebretsen L et al. ( 2013 ) . Oral health and impact on performance of athletes participating in the London 2012 Olympic Games: a cross-sectional study . Br J Sports Med vol. 47 , ( 16 ) 1054 - 1058 .

Adegun OK, Tomlins PH, Hagi-Pavli E, Bader DL, Fortune F ( 2013 ) . Quantitative optical coherence tomography of fluid-filled oral mucosal lesions . Lasers Med Sci vol. 28 , ( 5 ) 1249 - 1255 .

Mojgan H, Lesley B, Eleni H-P, Farida F ( 2013 ) . Expression of Suppressor of Cytokine Signalling (SOCS) 1 and 3 in Behcet's Disease . Frontiers in Immunology vol. 4 ,

Mojgan H, Lesley B, Farida F, Eleni H-P ( 2013 ) . Expression of Suppressor of Cytokine Signalling proteins (SOCS) 1 and 3 in Beh�et�s Disease . Frontiers in Immunology vol. 4 ,

Murray-Brown W, Croia C, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Pitzalis C, Bombardieri M ( 2013 ) . LESIONAL IL-21 EXPRESSION CORRELATES WITH FUNCTIONAL GERMINAL CENTER FORMATION AND T FOLLICULAR HELPER CELL INFILTRATION IN THE SALIVARY GLANDS OF SJOGREN'S SYNDROME . ANNALS OF THE RHEUMATIC DISEASES vol. 72 , 77 - 77 .

Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H ( 2012 ) . Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics . Exp Cell Res vol. 318 , ( 18 ) 2269 - 2283 .

Quax RAM, van Laar JAM, van Heerebeek R, Greiner K, Ben-Chetrit E, Stanford M, Wallace GR, Fortune F et al. ( 2012 ) . Glucocorticoid sensitivity in Behçet's disease . Endocr Connect vol. 1 , ( 2 ) 103 - 111 .

Pitiyage GN, Lim KP, Gemenitzidis E, Teh M-T, Waseem A, Prime SS, Tilakaratne WM, Fortune F et al. ( 2012 ) . Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing . J Oral Pathol Med vol. 41 , ( 6 ) 454 - 462 .

Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC et al. ( 2012 ) . Organ-specific management and supportive care in chronic graft-versus-host disease . Br J Haematol vol. 158 , ( 1 ) 62 - 78 .

Adegun OK, Tomlins PH, Hagi-Pavli E, McKenzie G, Piper K, Bader DL, Fortune F ( 2012 ) . Quantitative analysis of optical coherence tomography and histopathology images of normal and dysplastic oral mucosal tissues . Lasers Med Sci vol. 27 , ( 4 ) 795 - 804 .

Tsang SM, Brown L, Lin K, Liu L, Piper K, O'Toole EA, Grose R, Hart IR et al. ( 2012 ) . Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris . J Pathol vol. 227 , ( 1 ) 81 - 93 .

Heathfield S, Parker B, Zeef L, Bruce I, Alexander Y, Collins F, Stone M, Wang E et al. ( 2012 ) . Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function . Rheumatology vol. 51 , ( suppl_3 ) iii140 - iii184 .

Murray-Brown W, Croia C, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Pitzalis C, Bombardieri M ( 2012 ) . Lesional IL-21 expression correlates with functional germinal center formation and T follicular helper cell infiltration in the salivary glands of Sjogren's syndrome . IMMUNOLOGY . vol. 137 , 491 - 491 .

Murray-Brown W, Priori R, Tappuni T, Vartoukian S, Seoudi N, Picarelli G, Fortune F, Valesini G et al. ( 2012 ) . MONOCYTE-DERIVED IL-32 EXPRESSION CORRELATES WITH THE LEVEL OF INFLAMMATION IN SALIVARY GLANDS OF SJOGREN'S SYNDROME . RHEUMATOLOGY . vol. 51 , 176 - 176 .

Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P, Fortune F ( 2011 ) . Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease . Rheumatology (Oxford) vol. 50 , ( 10 ) 1849 - 1859 .

Aggarwal VR, Palmer NO, Nelson P, Ladwa R, Fortune F ( 2011 ) . Proposed career pathway for clinical academic general dental practitioners . Prim Dent Care vol. 18 , ( 4 ) 155 - 160 .

Durrani O, Banahan K, Sheedy FJ, McBride L, Ben-Chetrit E, Greiner K, Vaughan RW, Kondeatis E et al. ( 2011 ) . TIRAP Ser180Leu polymorphism is associated with Behcet's disease . Rheumatology (Oxford) vol. 50 , ( 10 ) 1760 - 1765 .

Mannan T, Jing S, Foroushania SH, Fortune F, Wan H ( 2011 ) . RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation . CELL PROLIFERAT vol. 44 , ( 4 ) 301 - 310 .

Moutasim K, Jenei V, Tilakaratne W, Fortune F, Thomas G ( 2011 ) . Oral submucous fibrosis: a role for epithelial regulation of stroma . British Journal of Oral and Maxillofacial Surgery vol. 49 ,

Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, Jalil A, Bornstein MM et al. ( 2011 ) . A systematic review of medical interventions for oral submucous fibrosis and future research opportunities . ORAL DIS vol. 17 , 42 - 57 .

Pitiyage GN, Slijepcevic P, Gabrani A, Chianea YG, Lim KP, Prime SS, Tilakaratne WM, Fortune F et al. ( 2011 ) . Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases . J Pathol vol. 223 , ( 5 ) 604 - 617 .

Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF et al. ( 2011 ) . Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis . J Pathol vol. 223 , ( 3 ) 366 - 377 .

Teh M-T, Parkinson EK, Thurlow JK, Liu F, Fortune F, Wan H ( 2011 ) . A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma . J Oral Pathol Med vol. 40 , ( 1 ) 67 - 76 .

Tomlins PH, Adegun O, Hagi-Pavli E, Piper K, Bader D, Fortune F ( 2010 ) . Scattering attenuation microscopy of oral epithelial dysplasia . Journal of Biomedical Optics vol. 15 , ( 6 ) Article 066003 ,

Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F ( 2010 ) . Impact of Behçet's syndrome on health-related quality of life: influence of the type and number of symptoms . Rheumatology (Oxford) vol. 49 , ( 11 ) 2165 - 2171 .

Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF et al. ( 2010 ) . Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis . J Pathol

Moutasim KA, Jenei V, Sapienza K, Marsh D, Marshall J, Fortune F, Tilakaratne WM, Hart IR et al. ( 2010 ) . Alkaloid-dependent upregulation of AlphavBeta6 integrin promotes oral submucous fibrosis . ORAL DIS vol. 16 , ( 6 ) 528 - 528 .

Abdelghani A, Tappuni A, Begum S, Makdissi J, Fortune F, Buchanan JAG ( 2010 ) . An unusual location for a salivary gland stone . ORAL DIS vol. 16 , ( 6 ) 564 - 564 .

Bernabe E, Marcenes W, Mather J, Phillips C, Fortune F ( 2010 ) . Impact of Behcet's Syndrome on quality of life . ORAL DIS vol. 16 , ( 6 ) 545 - 545 .

Begum SS, Tappuni AI, Abdelghani A, Seoudi N, Buchanan JAGB, Fortune F ( 2010 ) . Linear naevus sebaceous syndrome (LNSS) . ORAL DIS vol. 16 , ( 6 ) 563 - 563 .

Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B et al. ( 2010 ) . Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease . Nat Genet vol. 42 , ( 8 ) 698 - 702 .

Hagi-Pavli E, Macey M, Stewart J, Wallace G, Stanford M, Shirlaw P, Fortune F ( 2010 ) . AGE, GENDER AND DISEASE RELATED PLATELET AND NEUTROPHIL ACTIVATION IN BEHCET'S . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S128 - S128 .

Waseem A, Ali M, Odell EW, Fortune F, Teh M-T ( 2010 ) . Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma . Oral Oncol vol. 46 , ( 7 ) 536 - 542 .

Bergmeier LA, Adegun O, Seoudi N, Hamedi M, Hagi-Pavli E, Fortune F ( 2010 ) . INDUCIBLE HUMAN HEAT SHOCK PROTEIN (HSP70) IS ELEVATED IN THE SALIVA OF BEHCET'S PATIENTS . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S123 - S123 .

Hagi-Pavli E, Novak T, Bergmeier L, Seoudi N, Moeinian M, Fortune F ( 2010 ) . PLASMA AND SALIVA CYTOKINE PROFILES IN BEHCET'S DISEASE: DO CYTOKINE LEVELS IN PLASMA CORRELATE WITH LEVELS IN SALIVA? . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S129 - S129 .

Hagi-Pavli E, Bergmeier L, Khan I, Seoudi N, Fortune F ( 2010 ) . SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IN BEHCET'S PATIENTS SALIVA . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S128 - S128 .

Mather J, Marcenes W, Bernabe E, Phillips C, Fortune F ( 2010 ) . SYMPTOMS OF BEHCET'S SYNDROME IN A REPRESENTATIVE GROUP OF ADULTS IN THE UK . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S127 - S127 .

Seoudi N, Hagi-Pavli E, Bergmeier L, Stewart J, Curtis M, Fortune F ( 2010 ) . THE ORAL HEALTH AND MICROBIOTA OF UK BEHCET'S DISEASE PATIENTS . CLIN EXP RHEUMATOL vol. 28 , ( 4 ) S124 - S124 .

Gowrishankar S, Warner M, Roper M, Whitley S, Fortune F, Makdissi J ( 2010 ) . 20 Comparative study of high resolution ultrasound digital subtraction sialography and scintigraphy in the investigation of dry mouth . British Journal of Oral and Maxillofacial Surgery vol. 48 , s5 - s6 .

Makdissi J, Shunmegavelu K, Fortune F, Holmes S ( 2010 ) . P104 MRI as a useful diagnostic tool in internal derangement of the TMJ: can we predict the progression of the disease? . British Journal of Oral and Maxillofacial Surgery vol. 48 ,

Tsang S, Liu L, Teh M, Wheeler A, Piper K, Grose R, Hart I, Garrod D et al. ( 2010 ) . Novel role for human desmoglein 3 in regulating E-cadherin mediated adherens junctions through Src family kinase activation . JOURNAL OF INVESTIGATIVE DERMATOLOGY . vol. 130 , S33 - S33 .

Tsang SM, Liu L, Teh M-T, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F et al. ( 2010 ) . Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src . PloS ONE vol. 5 , ( 12 )

Nunn H, Lalli A, Fortune F, Croucher R ( 2009 ) . Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model . Br J Cancer vol. 101 Suppl 2 , ( Suppl 2 ) S68 - S72 .

Kappen JH, Wallace GR, Stolk L, Rivadeneira F, Uitterlinden AG, van Daele PLA, Laman JD, Kuijpers RWAM et al. ( 2009 ) . Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians . Rheumatology (Oxford) vol. 48 , ( 11 ) 1375 - 1377 .

Dalghous AM, Elkhabuli JO, Fortune F ( 2009 ) . Behçet's disease – a delay in diagnosis: why look in the mouth? . Oral Surgery vol. 2 , ( 1 ) 44 - 46 .

Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S et al. ( 2009 ) . Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease . J ORAL PATHOL MED vol. 38 , ( 5 ) 406 - 409 .

Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK et al. ( 2009 ) . FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation . PLoS One vol. 4 , ( 3 )

Curnow SJ, Pryce K, Modi N, Knight B, Graham EM, Stewart JE, Fortune F, Stanford MR et al. ( 2008 ) . Serum cytokine profiles in Behcet's disease: Is there a role for IL-15 in pathogenesis? . IMMUNOL LETT vol. 121 , ( 1 ) 7 - 12 .

Teh MT, Tilakaratne WM, Chaplin T, Young BD, Ariyawardana A, Pitiyage G, Lalli A, Stewart JE et al. ( 2008 ) . Fingerprinting genomic instability in oral submucous fibrosis . J Oral Pathol Med vol. 37 , ( 7 ) 430 - 436 .

Wallace GR, Murray PI, Fortune F, Kanawati C, Madanat W, Vaughan R, Kondeatis E, Stanford MR ( 2008 ) . AUTOIMMUNE GENETIC MASTERSWITCHES IN BEHCET'S DISEASE: AUTOIMMUNITY OR AUTOINFLAMMATION . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S15 - S15 .

Shafi S, Stanford MR, Fortune F, Graham EM, Wallace GR, Hayday AC ( 2008 ) . CIRCULATING LYMPHOCYTES IN BEHCET'S DISEASE . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S13 - S13 .

Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E et al. ( 2008 ) . CTLA-4 polymorphisms are not associated with ocular inflammatory disease . Tissue Antigens vol. 72 , ( 1 ) 49 - 53 .

Stewart JE, Mumcu G, Haque A, Hagi-Pavli E, Freysdot J, Direskeneli H, Shirlaw P, Wallace G et al. ( 2008 ) . DIFFERENTIAL CYTOKINE EXPRESSION BY PBMC'S OF BEHCET'S PATIENTS: INFLUENCE OF SERUM AND SALIVA . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S9 - S9 .

Hagi-Pavli E, Plequezuelos O, Seoudi N, Stewart JE, Shirlaw P, Wallace G, Stanford MR, Fortune F ( 2008 ) . EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND ITS LIGANDS IN THE ORAL CAVITY OF BEHCET'S DISEASE PATIENTS . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S9 - S10 .

Kappen JH, van Laar JAM, Stolk LB, Uitterlinden AG, van Daele PLA, Stanford MR, Fortune F, Wallace GR et al. ( 2008 ) . NOD2 (CARD15) SINGLE NUCLEOTIDE POLYMORPHISMS PROTECTIVE IN BEHCET'S DISEASE . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S14 - S14 .

Mumcu G, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford MR et al. ( 2008 ) . ORAL HEALTH AND QUALITY OF LIFE STATUS IN PATIENTS FROM UK AND TURKEY: A COMPARATIVE STUDY IN BEHCET'S DISEASE . CLIN EXP RHEUMATOL vol. 26 , ( 4 ) S5 - S6 .

Tilakaratne WM, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Stewart JE, Hagi-Pavli E et al. ( 2008 ) . Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis . J Oral Pathol Med vol. 37 , ( 6 ) 372 - 377 .

Fortune F, Kingston J, Barnes CS, Lehner T ( 2008 ) . Identification and characterization of IgA and Vicia villosa-binding T cell subsets in rheumatoid arthritis . Clinical & Experimental Immunology vol. 79 , ( 2 ) 202 - 208 .

FORTUNE F, COURTEAU M, WILLIAMS DG, LEHNER T ( 2008 ) . T and B cell responses following immunization with tetanus toxoid in IgA nephropathy . Clinical & Experimental Immunology vol. 88 , ( 1 ) 62 - 67 .

FORTUNE F, WALKER J, LEHNER T ( 2008 ) . The expression of γΔ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome . Clinical & Experimental Immunology vol. 82 , ( 2 ) 326 - 332 .

Fortune F, Fortune A, Kelly K, Sargent J, McGuckin S, Quinn F, Haslam K, O'Brien D et al. ( 2008 ) . T-CELL LARGE GRANULAR LYMPHOCYTE LEUKAEMIA: CLINICAL COURSE AND RESPONSE TO TREATMENT . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 104 - 104 .

Lalli A, Tilakaratne WM, Ariyawardana A, Fitchett C, Leigh IM, Hagi-Pavli E, Cruchley AT, Parkinson EK et al. ( 2008 ) . An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity . J Oral Pathol Med vol. 37 , ( 4 ) 211 - 220 .

Tilakaratne WM, Freysdottir J, Fortune F ( 2008 ) . Orofacial granulomatosis: review on aetiology and pathogenesis . J ORAL PATHOL MED vol. 37 , ( 4 ) 191 - 195 .

Kose O, Stewart J, Waseem A, Lalli A, Fortune F ( 2008 ) . Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease . Clin Exp Dermatol vol. 33 , ( 1 ) 62 - 69 .

Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC ( 2007 ) . Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma . J Oral Pathol Med vol. 36 , ( 10 ) 594 - 603 .

Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C et al. ( 2007 ) . The association of the PTPN22 620W polymorphism with Behcet's disease . ANN RHEUM DIS vol. 66 , ( 11 ) 1531 - 1533 .

Summers SA, Tilakaratne WM, Fortune F, Ashman N ( 2007 ) . Renal disease and the mouth . Am J Med vol. 120 , ( 7 ) 568 - 573 .

Bye L, Modi N, Stanford M, Kondeatis E, Vaughan R, Fortune F, Madanat W, Kanawati C et al. ( 2007 ) . CTLA-4 gene polymorphisms 49A/G and-318C/T do not associate with Behcet's disease . INFLAMM RES vol. 56 , S405 - S405 .

Palmer N, Fortune F ( 2007 ) . MJDF: frequently asked questions . Bulletin of The Royal College of Surgeons of England vol. 89 , ( 5 ) 172 - 173 .

Tilakaratne W, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Hagi-Pavli E, Lalli A et al. ( 2007 ) . P245 Up regulation of HIF-1a in the progression and malignant transformation of oral submucous fibrosis . Oral Oncology Supplement vol. 2 , ( 1 ) 204 - 205 .

Tilakaratne W, Iqball Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Hagi-Pavli E, Lalli A et al. ( 2007 ) . Up regulation of HIF-1 alpha in the progression and malignant transformation of oral submucous fibrosis . ORAL ONCOLOGY . vol. 2 , 204 - 205 .

Freysdottir J, Zhang S, Tilakaratne WM, Fortune F ( 2007 ) . Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment . Inflamm Bowel Dis vol. 13 , ( 4 ) 439 - 445 .

Hagi-Pavli E, Pleguezuelos O, Fazil BI, Stewart JE, Fortune F ( 2007 ) . Delayed healing of recurrent aphthous ulceration in Behcet's disease patients . IMMUNOLOGY . vol. 120 , 53 - 53 .

Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, Madanat W, Kanawati CA et al. ( 2007 ) . IL-10 genotype analysis in patients with Behçet's disease . Hum Immunol vol. 68 , ( 2 ) 122 - 127 .

Palmer N, Fortune F ( 2006 ) . A new assessment for today's dental graduates . Bulletin of The Royal College of Surgeons of England vol. 88 , ( 9 ) 300 - 301 .

FORTUNE F, WALKER J, LEFRANCOIS M, LEHNER T ( 2006 ) . The Expression of Carbohydrate Antigens in Activated T Cells and in Autoimmune Diseases . Scandinavian Journal of Immunology vol. 40 , ( 6 ) 636 - 642 .

Freysdottir J, Hussain L, Farmer I, Lau SH, Fortune F ( 2006 ) . Diversity of gamma delta T cells in patients with Behcet's disease is indicative of polyclonal activation . ORAL DIS vol. 12 , ( 3 ) 271 - 277 .

Dalghous AM, Freysdottir J, Fortune F ( 2006 ) . Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD . SCAND J RHEUMATOL vol. 35 , ( 6 ) 472 - 475 .

Stewart JE, Mumcu G, Curnow J, Wallace G, Stanford M, Fortune F ( 2005 ) . Saliva: contribution to inflammatory status in Bechet's disease . IMMUNOLOGY vol. 116 , 85 - 85 .

Fellowes R, Fortune F, Bergmeier LA, Lehner T ( 2005 ) . The effect of immunization with a 14‐kda streptococcal antigen on primate t cell and b cell responses . European Journal of Immunology vol. 18 , ( 4 ) 559 - 564 .

Wallace GR, Durrani O, Curnow J, Williams H, Hamburger J, Fortune F, Vaughan R, Murray PI ( 2005 ) . Toll-like receptor (TLR) expression in mouth ulcer biopsies from patients with Behcet's disease . INFLAMM RES vol. 54 , S190 - S190 .

Yang X, Ahmad T, Gogus F, Wallace GR, Madanat W, Kanawati CA, Stanford MR, Fortune F et al. ( 2005 ) . Analysis of the CC chemokine receptor 5 (CCR5)Delta 32 polymorphism in Behcet's disease (vol 31, pg 11, 2004) . INT J IMMUNOGENET vol. 32 , ( 3 ) 219 - 219 .

( 2005 ) . Corrigendum . International Journal of Immunogenetics vol. 32 , ( 3 ) 219 - 219 .

Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T et al. ( 2005 ) . CARD15 polymorphisms in Behçet's disease . Scand J Rheumatol vol. 34 , ( 3 ) 233 - 237 .

Nessim M, Sivaraj RR, Young SP, Fortune F, Stanford MR, Murray PI, Wallace GR ( 2005 ) . Metabonomic analysis of serum from patients with Behcet's disease: A new research tool? . INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . vol. 46 ,

Wallace GR, Pryce KM, Curnow SJ, Fortune F, Stewart JE, Modi N, Knight B, Stanford MR et al. ( 2005 ) . Multiplex bead analysis of cytokines in serum from patients with Behcet's disease . INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . vol. 46 ,

Murray PI, Durrani OM, Hamburger J, Williams H, Fortune F, Stewart J, Wallace GR ( 2005 ) . Toll-like receptor (TLR) expression in oral ulcer biopsies from Behcet's disease (BD) patients: A role for the innate immune system . INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . vol. 46 ,

Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR et al. ( 2004 ) . Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease . Eur J Immunogenet vol. 31 , ( 1 ) 11 - 14 .

Chen Y, Vaughan RW, Kondeatis E, Fortune F, Graham EM, Stanford MR, Wallace GR ( 2004 ) . Chemokine gene polymorphisms associate with gender in patients with uveitis . TISSUE ANTIGENS vol. 63 , ( 1 ) 41 - 45 .

FORTUNE F ( 2004 ) . Human Disease For Dentistry . Oxford University Press ( Oxford ),

DIRESKENELI H, HASAN A, SHINNICK T, MIZUSHIMA Y, VAN DER ZEE R, FORTUNE F, STANFORD MR, LEHNER T ( 2003 ) . Recognition of B‐Cell Epitopes of the 65 kDa HSP in Behçet's Disease . Scandinavian Journal of Immunology vol. 43 , ( 4 ) 464 - 471 .

Stark P, Fortune F ( 2003 ) . Teaching clinical skills in developing countries: are clinical skills centres the answer? . Educ Health (Abingdon) vol. 16 , ( 3 ) 298 - 306 .

WARR K, FORTUNE F, NAMIE‡ S, WILSON A, SHINNICK§ T, VAN DER ZEE¶ R, WILLIAMS G, LEHNER T ( 2003 ) . T‐cell epitopes recognized within the 65 000 MW hsp in patients‘qc with IgA nephropathy . Immunology vol. 91 , ( 3 ) 399 - 405 .

Chen Y, Stanford MR, Wallace GR, Vaughan RW, Kondeatis E, Fortune F ( 2003 ) . Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease . Br J Ophthalmol vol. 87 , ( 8 ) 1048 - 1049 .

Chen Y, Vaughan R, Kondeatis E, Graham EM, Fortune F, Wallace GR, Stanford MR ( 2003 ) . Altered distribution of Polymorphisms in the promoter gene for IL-10 in patients with Behcet's disease but not those with idiopathic retinal vasculitis . INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . vol. 44 , U607 - U607 .

Ahmad T, Zhang LN, Gogus F, Wallace G, Yang XS, Madanat W, James T, Neville M et al. ( 2003 ) . NOD2/CARD15: a genetic link between Behcet's disease (BD) and Crohn's disease (CD)? . GASTROENTEROLOGY . vol. 124 , A373 - A373 .

Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J et al. ( 2003 ) . Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? . Arthritis Rheum vol. 48 , ( 3 ) 807 - 813 .

Fortune F ( 2003 ) . Can you catch Behçet's disease? . J Lab Clin Med vol. 141 , ( 1 ) 5 - 6 .

Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al. ( 2002 ) . Behcet or Crohn disease? Combination HLA-B*51 and CARD15 molecular typing may help decide . GASTROENTEROLOGY vol. 122 , ( 4 ) A301 - A301 .

Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al. ( 2002 ) . Behcet's disease and TNF: A missing genetic link? . GUT vol. 50 , A14 - A15 .

Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al. ( 2002 ) . Behcet's or Crohn's disease? Combination HLA-B*51 and NOD2 molecular typing may help decide . GUT vol. 50 , A15 - A15 .

Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al. ( 2002 ) . Behcets disease and TNF: A missing genetic link? . GASTROENTEROLOGY vol. 122 , ( 4 ) A300 - A300 .

Freysdottir J, Lau S-H, Fortune F ( 2001 ) . γδ T cells in Behçet’s disease (BD) and recurrent aphthous stomatitis (RAS) . Clinical & Experimental Immunology vol. 118 , ( 3 ) 451 - 457 .

Farmer I, Freysdottir J, Dalghous AM, Fortune F ( 2001 ) . Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ . J Oral Pathol Med vol. 30 , ( 2 ) 113 - 120 .

McMillan ND, Finlayson O, Fortune F, Fingleton M, Daly D, Townsend D, McMillan DDG, Dalton MJ ( 1999 ) . The fibre drop analyser: a new multianalyser analytical instrument with applications in sugar processing and for the analysis of pure liquids . Measurement Science and Technology vol. 3 , ( 8 )

Sanderson JD, Barnard K, Shirlaw P, Odell E, Chinyama C, Fortune F, Freysdottir J, Twitchen M et al. ( 1999 ) . The oral and intestinal features of oro-facial granulomatosis . GASTROENTEROLOGY . vol. 116 , A811 - A811 .

Freysdottir J, Hussain L, Farmer I, Lau SH, Fortune F ( 1999 ) . γδ usage in patients with Bechet's disease . JOURNAL OF DENTAL RESEARCH . vol. 78 , 1080 - 1080 .

CARPENTER GH, FORTUNE F, FREYSDOTTIR J, PROCTOR GB ( 1998 ) . 100 Characterising lectin binding to the O-linked sugars of immunoglobulin A1 . Biochemical Society Transactions vol. 26 , ( 4 ) s384 - s384 .

Buchanan J, Morris A, Fortune F ( 1997 ) . A mechanic who coughed up blood for 15 months . The Lancet vol. 350 , ( 9070 )

Freysdottir J, Twitchen MJ, Fortune F ( 1997 ) . Recurrent oral ulceration — The role of activated αβ and γδ T cells . Immunology Letters vol. 56 ,

Fortune F, Freysdottir J, Walker J ( 1997 ) . T cells expressing γδ receptors and Fcα receptors in Behcet's disease . Immunology Letters vol. 56 ,

Twitchen MJ, Freysdottir J, Fortune F ( 1997 ) . Laser therapy, polycystic ovary syndrome and enlarged salivary glands . JOURNAL OF DENTAL RESEARCH . vol. 76 , 1078 - 1078 .

Freysdottir J, Twitchen MJ, Fortune F ( 1997 ) . Recurrent oral ulceration - The role of gamma delta T cells . JOURNAL OF DENTAL RESEARCH . vol. 76 , 1078 - 1078 .

Gaston JSH, Hasan A, Fortune F, Wilson A, Lehner T ( 1996 ) . Role of γδ T cells in Behcet's disease . The Lancet vol. 347 , ( 9015 ) 1631 - 1632 .

Hasan A, Fortune F, Wilson A, Warr K, Lehner T, Sanderson J, Shinnick T, Mizushima Y et al. ( 1996 ) . Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease . The Lancet vol. 347 , ( 9004 ) 789 - 794 .

Hasan A, Fortune F, Wilson A, Lehner T ( 1996 ) . Role of gamma delta T cells in Behcet's disease - Reply . LANCET vol. 347 , ( 9015 ) 1632 - 1632 .

Fortune F, Hasan A, Wilson A, Warrik K, Lehner T ( 1996 ) . Stress proteins and their role in the immunoregulation and diagnosis of Behcet's disease . JOURNAL OF DENTAL RESEARCH . vol. 75 , 3338 - 3338 .

Buchanan JA, Hasan AS, Churchill L, Fortune F ( 1995 ) . Atypical palatal ulceration . Postgraduate Medical Journal vol. 71 , ( 831 )

WARR KJ, FORTUNE F, NAMIE S, WILSON A, WILLIAMS DG, LEHNER T ( 1995 ) . EPITOPE MAPPING WITH 65KD HEAT-SHOCK PROTEIN IN IGA NEPHROPATHY . JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY . vol. 6 , 857 - 857 .

Rudd P, Fortune F, Lehner T, Parekh R, Patel T, Wormald M, Malhotra R, Sim R et al. ( 1995 ) . Lectin-Carbohydrate Interactions in Disease . Advances in Experimental Medicine and Biology vol. 376 , 147 - 152 .

Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T ( 1994 ) . A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD . Immunology vol. 83 , ( 1 ) 99 - 106 .

Fortune F ( 1994 ) . Book Reviews . European Journal of Orthodontics vol. 16 , ( 3 ) 247 - 247 .

Buchanan JAG, Fortune F ( 1994 ) . Bilateral parotid enlargement as a presenting feature of bulimia nervosa in a post-adolescent male . Postgraduate Medical Journal vol. 70 , ( 819 ) 27 - 30 .

WARR K, FORTUNE F, NAIME S, WILLIAMS DG, LEHNER T ( 1994 ) . T-CELL EPITOPE MAPPING IN IGA NEPHROPATHY . JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY . vol. 5 , 773 - 773 .

Fortune F, Buchanan JAG ( 1993 ) . Oral lichen planus and coeliac disease . The Lancet vol. 341 , ( 8853 ) 1154 - 1155 .

Fortune F, Lehner T ( 1993 ) . P 131 T cells expressing γδ receptors and cytophilic IgA1 antibodies in Behçet's disease . La Revue de Médecine Interne vol. 14 ,

McMillan ND, Fortune F, Finlayson O, McMillan DDG, Townsend D, Daly D, Fingleton M, Dalton M ( 1992 ) . A fiber drop analyzer: A new analytical instrument for the individual, sequential, or collective measurement of the physical and chemical properties of liquids . Review of Scientific Instruments vol. 63 , ( 6 ) 3431 - 3454 .

FORTUNE F, COURTEAU M, WILLIAMS DG, LEHNER T ( 1992 ) . T-CELL AND B-CELL RESPONSES FOLLOWING IMMUNIZATION WITH TETANUS TOXOID IN IGA NEPHROPATHY . CLINICAL AND EXPERIMENTAL IMMUNOLOGY vol. 88 , ( 1 ) 62 - 67 .

LEHNER T, FORTUNE F, LAVERY E, STUDD M ( 1991 ) . RECENT ADVANCES IN T-CELL IMMUNOREGULATION AND IN THE MICROBIAL CAUSES OF BEHCETS-DISEASE . BEHCETS DISEASE . vol. 8 , 463 - 473 .

Fortune F, Lehner T ( 1988 ) . Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus . Clinical & Experimental Immunology vol. 74 , ( 1 ) 100 - 104 .

Fortune F ( 1987 ) . Slide Interpretation in Oral Diseases and the Oral Manifestations of Systemic Diseases . Postgraduate Medical Journal vol. 63 , ( 736 ) 158 - 159 .

FORTUNE F ( 1987 ) . A DOUBLE IMMUNOFLUORESCENCE CYTOFLUOROMETRIC INVESTIGATION OF SUBSETS OF T-CELLS IN AUTOIMMUNE-DISEASES . JOURNAL OF DENTAL RESEARCH . vol. 66 , 835 - 835 .

Symons C, Fortune F, Greenbaum RA, Dandona P ( 1985 ) . Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association . Heart vol. 54 , ( 5 )

FORTUNE F, GREENBAUM RA, DANDONA P, SYMONS C ( 1985 ) . CARDIAC-HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY AND HYPERPARATHYROIDISM - AN ASSOCIATION . BRITISH HEART JOURNAL . vol. 53 , 112 - 113 .